69 / 89
69
25.
Harvey GR, Butts S, Rands AL, Patel Y,
McHugh
NJ.
Clinical
and
serological
associations
with
anti-RNA
polymerase
antibodies in systemic sclerosis. Clin Exp
Immunol 1999;117:395-402.
26.
Tan FK, Arnett FC, Reveille JD, Ahn C, Antohi
S, Sasaki T, Nishi Bona CA. Autoantibodies to
fibrillin 1 in systemic sclerosis: ethnic
differences in antigen recognition and lack of
correlation with specific clinical features or HLA
alleles. Arthritis Rheum 2000;43:2464-71.
27.
Tan FK, Arnett FC, Antohi S, Saito S, Mirarchi
A, Spiera H, et al. Autoantibodies to the
extracellular matrix microfibrillar protein,
fibrillin-1, in patients with scleroderma and
other connective tissue diseases. J Immunol
1999;163:1066-72.
28.
Steen VD. Autoantibodies in systemic sclerosis.
Semin Arthritis Rheum 2005:35:35-42.
29.
Kaldas M, Khanna PP, Furst DE, Clements PJ,
Wong WK, Seibold JR, et al. Sensitivity to
change of the modified Rodnan skin score in
diffuse systemic sclerosis--assessment of
individual body sites in two large randomized
controlled trials. Rheumatology (Oxford)
2009;48:1143-6.
30.
Merkel PA, Silliman NP, Denton CP, Furst DE,
Khanna D, Emery P, et al. Validity, reliability,
and feasibility of durometer measurements of
scleroderma skin disease in a multicenter
treatment trial. Arthritis Rheum 2008;59:699-705.